What is the normal fasting insulin range for a middle‑aged South Asian postmenopausal female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal Range of Fasting Insulin for Middle-Aged South Asian Postmenopausal Females

For a middle-aged South Asian postmenopausal female, the normal fasting insulin range is approximately 2.6-14.6 µIU/mL (or mIU/L), with a median around 7.7 µIU/mL, based on the most recent population-specific data from South Asian populations.

Evidence-Based Reference Ranges

The most relevant and recent evidence comes from a 2026 study establishing reference intervals specifically in a South Asian population from Nepal 1. This study provides:

  • Fasting insulin: 2.63-14.56 µIU/mL (median 7.69 µIU/mL)
  • HOMA-IR: 0.56-3.50 (for insulin resistance assessment)
  • HOMA-%S: 58.83-233.20 (for insulin sensitivity)

This represents the first population-specific reference intervals for South Asians and is directly applicable to your patient population.

Important Population-Specific Considerations

South Asian populations demonstrate distinct insulin physiology compared to Western populations:

  • South Asians typically have higher fasting insulin levels and greater insulin resistance at similar BMI levels compared to white populations 2
  • They show an inadequate pancreatic beta-cell reserve, with steeper age-related increases in fasting glucose 2
  • Post-load insulin levels are consistently higher in South Asians (by approximately 0.7 log pmol/L) 2

Age and Menopausal Status Impact

For middle-aged individuals, fasting insulin shows a decreasing trend with age in both genders 3. However, South Asian women specifically demonstrate:

  • Higher baseline insulin levels compared to white populations
  • Progressive decline in insulin sensitivity with age (HOMA2-%S)
  • Less robust age-related increase in beta-cell function (HOMA2-%B) compared to white individuals 2

Clinical Interpretation Thresholds

For identifying insulin resistance or metabolic dysfunction:

  • Fasting insulin ≥10 mIU/L suggests insulin resistance in women 4, 5
  • HOMA-IR ≥2.0 indicates insulin resistance in women 5
  • Values above these thresholds warrant evaluation for metabolic syndrome, even with only 1-2 metabolic criteria present

Comparative Reference Values from Other Studies

Supporting data from Iranian adults (similar ethnic background) shows 3:

  • Women: 2.34-11.98 µIU/mL (95% reference interval)
  • HOMA-IR: 0.40-1.80
  • QUICKI: 0.33-0.42

Korean population data provides additional context 6:

  • Median fasting insulin: 7.69 µIU/mL
  • 75th percentile: 9.82 µIU/mL
  • Metabolic syndrome risk threshold: 9.7 µIU/mL

Critical Caveats

These reference ranges assume:

  • Normal BMI (18.5-24.9 kg/m²)
  • No renal or hepatic insufficiency
  • No medications affecting insulin sensitivity
  • Fasting state (8-12 hours)
  • Standardized assay methods (chemiluminescence immunoassay preferred)

Laboratory method matters: The thresholds were validated using specific immunometric assays (IRMA or ICMA methods) 7. Your laboratory should validate these ranges with their specific assay platform.

Practical Application

For your middle-aged South Asian postmenopausal patient:

  1. Normal range: 2.6-14.6 µIU/mL
  2. Optimal target: <10 µIU/mL to minimize metabolic risk
  3. Concerning if: ≥10 µIU/mL (suggests insulin resistance)
  4. Highly abnormal if: >14.6 µIU/mL (above 97.5th percentile)

Consider concurrent assessment of:

  • Fasting glucose (should be <5.3 mmol/L or <95 mg/dL)
  • HOMA-IR calculation (normal <2.0 for women)
  • Waist circumference and blood pressure (biological determinants of insulin levels) 3

The use of population-specific reference ranges is essential because Western-derived values systematically underestimate insulin resistance risk in South Asian populations, potentially delaying intervention for metabolic syndrome and type 2 diabetes prevention.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.